Cargando…

Identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in-depth analysis to inform the development of a core outcome set

BACKGROUND: Many completed trials of interventions for uncomplicated gallstone disease are not as helpful as they could be due to lack of standardisation across studies, outcome definition, collection and reporting. This heterogeneity of outcomes across studies hampers useful synthesis of primary st...

Descripción completa

Detalles Bibliográficos
Autores principales: Cruickshank, Moira, Newlands, Rumana, Blazeby, Jane, Ahmed, Irfan, Bekheit, Mohamed, Brazzelli, Miriam, Croal, Bernard, Innes, Karen, Ramsay, Craig, Gillies, Katie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231013/
https://www.ncbi.nlm.nih.gov/pubmed/34168025
http://dx.doi.org/10.1136/bmjopen-2020-045568
_version_ 1783713336452448256
author Cruickshank, Moira
Newlands, Rumana
Blazeby, Jane
Ahmed, Irfan
Bekheit, Mohamed
Brazzelli, Miriam
Croal, Bernard
Innes, Karen
Ramsay, Craig
Gillies, Katie
author_facet Cruickshank, Moira
Newlands, Rumana
Blazeby, Jane
Ahmed, Irfan
Bekheit, Mohamed
Brazzelli, Miriam
Croal, Bernard
Innes, Karen
Ramsay, Craig
Gillies, Katie
author_sort Cruickshank, Moira
collection PubMed
description BACKGROUND: Many completed trials of interventions for uncomplicated gallstone disease are not as helpful as they could be due to lack of standardisation across studies, outcome definition, collection and reporting. This heterogeneity of outcomes across studies hampers useful synthesis of primary studies and ultimately negatively impacts on decision making by all stakeholders. Core outcome sets offer a potential solution to this problem of heterogeneity and concerns over whether the ‘right’ outcomes are being measured. One of the first steps in core outcome set generation is to identify the range of outcomes reported (in the literature or by patients directly) that are considered important. OBJECTIVES: To develop a systematic map that examines the variation in outcome reporting of interventions for uncomplicated symptomatic gallstone disease, and to identify other outcomes of importance to patients with gallstones not previously measured or reported in interventional studies. RESULTS: The literature search identified 794 potentially relevant titles and abstracts of which 137 were deemed eligible for inclusion. A total of 129 randomised controlled trials, 4 gallstone disease specific patient-reported outcome measures (PROMs) and 8 qualitative studies were included. This was supplemented with data from 6 individual interviews, 1 focus group (n=5 participants) and analysis of 20 consultations. A total of 386 individual recorded outcomes were identified across the combined evidence: 330 outcomes (which were reported 1147 times) from trials evaluating interventions, 22 outcomes from PROMs, 17 outcomes from existing qualitative studies and 17 outcomes from primary qualitative research. Areas of overlap between the evidence sources existed but also the primary research contributed new, unreported in this context, outcomes. CONCLUSIONS: This study took a rigorous approach to catalogue and map the outcomes of importance in gallstone disease to enhance the development of the COS ‘long’ list. A COS for uncomplicated gallstone disease that considers the views of all relevant stakeholders is needed.
format Online
Article
Text
id pubmed-8231013
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-82310132021-07-09 Identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in-depth analysis to inform the development of a core outcome set Cruickshank, Moira Newlands, Rumana Blazeby, Jane Ahmed, Irfan Bekheit, Mohamed Brazzelli, Miriam Croal, Bernard Innes, Karen Ramsay, Craig Gillies, Katie BMJ Open Surgery BACKGROUND: Many completed trials of interventions for uncomplicated gallstone disease are not as helpful as they could be due to lack of standardisation across studies, outcome definition, collection and reporting. This heterogeneity of outcomes across studies hampers useful synthesis of primary studies and ultimately negatively impacts on decision making by all stakeholders. Core outcome sets offer a potential solution to this problem of heterogeneity and concerns over whether the ‘right’ outcomes are being measured. One of the first steps in core outcome set generation is to identify the range of outcomes reported (in the literature or by patients directly) that are considered important. OBJECTIVES: To develop a systematic map that examines the variation in outcome reporting of interventions for uncomplicated symptomatic gallstone disease, and to identify other outcomes of importance to patients with gallstones not previously measured or reported in interventional studies. RESULTS: The literature search identified 794 potentially relevant titles and abstracts of which 137 were deemed eligible for inclusion. A total of 129 randomised controlled trials, 4 gallstone disease specific patient-reported outcome measures (PROMs) and 8 qualitative studies were included. This was supplemented with data from 6 individual interviews, 1 focus group (n=5 participants) and analysis of 20 consultations. A total of 386 individual recorded outcomes were identified across the combined evidence: 330 outcomes (which were reported 1147 times) from trials evaluating interventions, 22 outcomes from PROMs, 17 outcomes from existing qualitative studies and 17 outcomes from primary qualitative research. Areas of overlap between the evidence sources existed but also the primary research contributed new, unreported in this context, outcomes. CONCLUSIONS: This study took a rigorous approach to catalogue and map the outcomes of importance in gallstone disease to enhance the development of the COS ‘long’ list. A COS for uncomplicated gallstone disease that considers the views of all relevant stakeholders is needed. BMJ Publishing Group 2021-06-24 /pmc/articles/PMC8231013/ /pubmed/34168025 http://dx.doi.org/10.1136/bmjopen-2020-045568 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Surgery
Cruickshank, Moira
Newlands, Rumana
Blazeby, Jane
Ahmed, Irfan
Bekheit, Mohamed
Brazzelli, Miriam
Croal, Bernard
Innes, Karen
Ramsay, Craig
Gillies, Katie
Identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in-depth analysis to inform the development of a core outcome set
title Identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in-depth analysis to inform the development of a core outcome set
title_full Identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in-depth analysis to inform the development of a core outcome set
title_fullStr Identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in-depth analysis to inform the development of a core outcome set
title_full_unstemmed Identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in-depth analysis to inform the development of a core outcome set
title_short Identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in-depth analysis to inform the development of a core outcome set
title_sort identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in-depth analysis to inform the development of a core outcome set
topic Surgery
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231013/
https://www.ncbi.nlm.nih.gov/pubmed/34168025
http://dx.doi.org/10.1136/bmjopen-2020-045568
work_keys_str_mv AT cruickshankmoira identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset
AT newlandsrumana identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset
AT blazebyjane identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset
AT ahmedirfan identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset
AT bekheitmohamed identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset
AT brazzellimiriam identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset
AT croalbernard identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset
AT inneskaren identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset
AT ramsaycraig identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset
AT gillieskatie identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset